HealthEquity Q2 EPS $0.53 Beats $0.47 Estimate, Sales $243.50M Beat $238.89M Estimate
Portfolio Pulse from Benzinga Newsdesk
HealthEquity reported Q2 earnings of $0.53 per share, beating the analyst consensus estimate of $0.47 by 12.77%. This is a 60.61% increase from the same period last year. The company also reported quarterly sales of $243.50 million, beating the analyst consensus estimate of $238.89 million by 1.93%. This is an 18.12% increase from the same period last year.
September 05, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HealthEquity's Q2 earnings and sales beat analyst estimates, showing significant YoY growth. This positive financial performance could boost investor confidence.
HealthEquity's Q2 earnings and sales exceeded analyst estimates, indicating strong financial performance. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100